Open Stent Solution

medical devices

About

Open Stent Solution is a medtech company based in France, founded in 2018. The company specializes in innovative cardiovascular technologies, particularly for heart valve diseases. Its flagship product, Cornelis™, is a transcatheter valve replacement system designed to treat mitral and tricuspid regurgitation, offering a minimally invasive alternative for patients at high surgical risk. The company's unique open stent design allows for longitudinal expansion, which enhances procedural outcomes and patient safety. Open Stent Solution focuses on addressing unmet clinical needs in valvular heart disease, targeting healthcare providers and hospitals that care for patients unsuitable for traditional open-heart surgery. The company is committed to advancing its product development through significant technical milestones and ongoing clinical studies.

Technologies

Outlook Microsoft Office 365 Mobile Friendly Remote AI

Keywords

medical equipment manufacturing biotech industry ribbon valve technology biomedical research medical device design non-surgical valve implant biotechnology biotech innovation heart failure treatment medical equipment and supplies manufacturing biotech collaboration implantable valve low-profile delivery system heart valve engineering valve replacement biodegradable valve biotech industry partnerships valve durability testing valve design minimally invasive surgery clinical trials valvular heart disease biomedical device biomedical patents medtech cornelis valve biotech venture capital biotech startup ecosystem medical research medical device testing

Location

41 Avenue Paul Claudel, Dury, Hauts-de-France, France, 80480

Related Companies

Companies in the same industry